Esr1 has been shown to suppress proliferation, migration, and invasion in liver cancer cells; its underexpression predicts a worse prognosis in HCC patients; and female liver cancers specifically upregulate a miRNA that reduces Esr1 expression [19,20,21,22,23,24]. The gene discussed is ESR1; the disease is hepatocellular carcinoma.